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INTRODUCTION
The adult mammalian brain contains a population of neural stem cells (NSCs) in the subventricular zone (SVZ) that express NESTIN and glial fibrillary acidic protein (GFAP). Adult NSCs give rise to neuroblasts, which migrate to the olfactory bulb and generate new neurons (Lois and Alvarez-Buylla, 1994) . Following brain injury, these neuroblasts can migrate to the lesion site (Arvidsson et al., 2002) following cues released by cells at the injury including reactive glia (Leong and Turnley, 2011) . Nevertheless, the brain remains limited in its ability to generate new neurons after injury.
Reactive astrocytes (RAs) are a heterogeneous population of cells (Molofsky et al., 2012) that play key roles in the CNS response to injury, such as restricting inflammation, preventing neuronal loss, and repairing the blood brain barrier (Burda and Sofroniew, 2014) . Recently, two types of RAs have been defined based on their structural properties: (1) newly proliferated elongated astrocytes that express progenitor markers such as SOX2, brain lipid binding protein (BLBP), and RC2, and (2) stellate astrocytes that derive from resident cortical astrocytes (Wanner et al., 2013) . It has also been suggested that a subset of RAs has the potential to convert to multipotent, self-renewing NSCs capable of NS formation in vitro (Buffo et al., 2008; Shimada et al., 2012) . However, a recent study has described a subpopulation of RAs originating from the SVZ that migrate to the damaged tissue and are distinct from resident RAs in a postnatal mouse model of hypoxia/ischemia (Benner et al., 2013) . This led us to investigate with genetic tools: (1) the origin of cortical neurospheres in two models of stroke, and (2) the contribution of SVZ cells to the astrogliosis that is seen following brain injury.
Lineage tracking using tamoxifen inducible Nestin-CreER T2 (Imayoshi et al., 2006; Lagace et al., 2007) and Cre conditional reporter (Madisen et al., 2010; Srinivas et al., 2001) transgenic mice revealed that cortical NSs originate from SVZ-derived NSCs that migrate to the stroke lesion after injury. These cortical SVZderived cells rapidly differentiate and give rise to a subpopulation of RAs that contribute to the astrocyte scar, thus highlighting a role for the SVZ in post injury gliosis. Last, we demonstrate that the transcription factor Ascl1 (also known as Mash1) can convert SVZ derived RAs to neurons, providing a new target for cellular conversion strategies aimed at enhancing neurogenesis.
RESULTS

Neurosphere Forming Capacity of Cells in the Injured Cortex
To detect NSCs in the injured adult cortex, we performed the NS assay on tissue derived from the injured cortex and the SVZ ( Figure 1A ) of mice 4 days after an endothelin-1 (ET-1) induced stroke. Similar to previous reports (Buffo et al., 2008; Erlandsson et al., 2011; Shimada et al., 2012) , NSs formed from the SVZ and stroke-injured cortex ( Figures 1B and 1C ), but never from the contralateral (uninjured) cortex ( Figure 1C ). While the average size of cortex-derived NSs (ctxNSs) was less than SVZ derived NSs (svzNSs) ( Figure S1A ), both populations displayed the cardinal properties of stem cells; selfrenewal and multipotency (Potten and Loeffler, 1990) . Single NS passaging revealed extended self-renewal (up to passage 5, the longest time examined) with no difference in NS number at each passage ( Figure S1B ). Furthermore, ctxNSs and svzNSs (C) Number of NSs formed from the uninjured and stroke-injured cortex and SVZ (** = p = 0.001, unpaired t test with Welch's correction, t(8) = 5.006, data represent ±SEM, n ctx = 11 mice, and n svz = 9 mice). (D) Diagram of injection sites lateral and caudal to the original sensory-motor cortex lesion site.
(E) Number of NSs formed from the cortex and SVZ in lesions lateral and caudal to the original sensory-motor cortex lesion (smctx) and after PVD (*** = p < 0.001, unpaired t test, t(12) = 9.785, data represent ±SEM, n smctx_ctx = 9 mice, n smctx_SVZ = 5 mice; *** = p < 0.001, unpaired t test, t(6) = 8.454, data represent ±SEM, n lat_ctx = 4 mice, n lat_SVZ = 4 mice; * = p < 0.05, unpaired t test, t(4) = 3.908, data represent ±SEM, n caud_ctx = 3 mice, n caud_SVZ = 3 mice; and * = p < 0.05, unpaired t test, t(12) = 2.978, data represent ±SEM, n PVD_ctx = 7 mice, n PVD_SVZ = 7 mice).
(F) Number of NSs at passage 4 and passage 10 from the original sensory-motor cortex lesion, lateral, and caudal to that site and after PVD (n.s., unpaired t test, t(5) passage4_et-1 = 0.1879, t(11) passage10_et-1 = 1.1016, t(12) passage4_PVD = 0.3755, t(10) passage10_PVD = 1.910, t(3) passage4_lat = 0.07205, t(2) passage10_late = 0.112, (legend continued on next page) were multipotent ( Figure S1C ), with similar differentiation profiles ( Figure S1D ). We asked if these findings were specific to the site of cortical injury or the model of stroke. In a first series of experiments, we assessed NS formation in response to ET-1 strokes in different regions of the cortex. NSs formed from the strokeinjured cortex at lesion sites both lateral (Figures 1D and 1E) and caudal ( Figures 1D and 1E ) to the sensory-motor cortex lesions originally examined, revealing that the response was not regionally specific within the cortex. In a second series of experiments, we used a different model of stroke, pial vessel disruption (PVD) (Hua and Walz, 2006; Kolb et al., 2007) . PVD to the sensory-motor cortex resulted in the generation of cortical derived NSs, identical to what was observed with ET-1 stroke ( Figure 1E ). Bulk passaging showed that, akin to our original stroke paradigm, NSs from lateral, caudal, and PVD stroke sites showed extended passaging (up to Passage 10, the longest time examined), with no difference in NS number between ctxNSs and svzNSs ( Figure 1F ). Further, no difference was seen in the percent of multipotent ctxNSs versus svzNSs ( Figure S1E ).
Cortical Derived Neurospheres Are Derived from Migratory SVZ Stem Cells
With the goal of distinguishing between ctxNSs and svzNSs, we took advantage of the Nestin-CreER T2 ;tdTomato fl double transgenic mouse (Imayoshi et al., 2006; Lagace et al., 2007) , which enables permanent tdTOMATO labeling of cells expressing NESTIN during the time of Cre recombinase induction with tamoxifen. NESTIN is expressed by neural stem and progenitor cells in vivo (Morshead et al., 1994) . We crossed these animals with hGFAP-GFP mice that permit visualization of GFAP expressing astrocytes and NSCs (Zhuo et al., 1997) . The Nestin-CreER T2 ; tdTomato fl ;hGFAP-GFP triple transgenic mice were fed tamoxifen for 2 weeks and chased for 2-3 weeks ( Figure 1G ), ensuring labeling of SVZ cells with tdTOMATO and eliminating the possibility of tamoxifen uptake by RAs that express NESTIN after stroke (Clarke et al., 1994) . Tamoxifen fed triple transgenic mice gave rise to GFP+/tdTOMATO+ svzNSs, while the unfed mice gave rise to GFP+/tdTOMATOÀ svzNSs ( Figure S1F ). Most striking, all of the ctxNSs from stroke lesioned, tamoxifen fed Nestin-CreER T2 ;tdTomato fl ;hGFAP-GFP mice were GFP+/tdTOMATO+ ( Figure 1G ) compared to the control unfed mice, where none of the ctxNSs expressed tdTOMATO. Based on the total number of cells we isolated from the stroke-lesioned site, we estimate that approximately 35 ctxNS forming cells are found in the injured cortex at 4 days post stroke. We repeated this experiment in a second strain of Nestin-CreER T2 mice (Lagace et al., 2007) to ensure that the findings were not the result of tamoxifen independent tdTOMATO expression (Imayoshi et al., 2006) or recombina-tion in NESTIN negative cells (Sun et al., 2014) . Nestin-CreER T2 mice were crossed with a YFP fl Cre conditional reporter and fed tamoxifen for 2 weeks, followed by a 2-3 week chase ( Figure 1H ) to label SVZ cells and not RAs with YFP ( Figure S1G ). Tamoxifen fed mice gave rise to both YFP+ SVZ ( Figure 1H ) and ctx derived NSs ( Figures 1H and S1H ). Moreover, YFP+ ctxNSs were seen after ET-1 strokes both lateral and caudal to the original site, as well as after PVD lesions ( Figure 1I ). Importantly, the frequency of labeling in ctxNSs was similar to the frequency of labeling in the corresponding SVZ (Table S1 ), supporting the conclusion that ctxNSs are derived from the SVZ.
To confirm the finding that GFAP+ NSCs were giving rise to ctxNSs, we took advantage of the GFAP-TK mice (Bush et al., 1998 (Bush et al., , 1999 ) that express herpes simplex virus thymidine kinase (TK) from the GFAP promoter. In these mice, proliferating GFAP+ cells will undergo cell death in the presence of ganciclovir (GCV) (Imura et al., 2003; Morshead et al., 2003) . Control (non-TK) mice that received an ET-1 stroke gave rise to ctxNSs in the presence of GCV, however, there was a complete loss of ctxNSs from ET-1 stroke-injured GFAP-TK mice in the presence of GCV (Figure S1I) . These findings are consistent with the conclusion that ctxNSs are derived from GFAP+ NSCs.
To further demonstrate the SVZ origin of ctxNSs, we used a well-established SVZ ablation paradigm (Doetsch et al., 1999) to eliminate proliferating precursors in the SVZ. We predicted that ablating SVZ precursors would result in a loss of ctxNSs at 4 days post ET-1 stroke. Cytosine b-D-arabinoside (AraC) was intraventricularly infused prior to performing the NS assays. Nestin-CreER T2 ;tdTomato fl ;hGFAP-GFP mice received AraC for 10 days prior to stroke and for 4 days post stroke (AraC, 10 days+ and 4 days+; Figure 1J (i)). As previously reported (Doetsch et al., 1999) , AraC infusion caused a reduction in the number of svzNSs and, as predicted, virtually eliminated ctxNS formation ( Figure 1K ). We used KI-67 to assess the possibility that intraventricular AraC administration was depleting the proliferating cells in the stroke-injured cortex and this was accounting for the loss of NS forming cells from the cortex. Importantly, we observed KI-67+/GFAP+ cells within the injured cortex demonstrating that the intraventricular AraC infusion did not eliminate resident cortical cells that divide post stroke ( Figure 1L ). Hence, the loss of ctxNSs was not due to the AraC kill of mitotically active cells within the lesioned cortex, but rather was the result of eliminating proliferating SVZ cells.
Previous studies have shown the rapid repopulation of the SVZ following ablation of the neural precursor pool (Doetsch et al., 1999; Morshead et al., 1994) . We reasoned that AraC withdrawal at the time of stroke would permit repopulation of the SVZ and subsequent migration of NSCs to the injured cortex. t(4) passage4_caud = 1.349, t(4) passage10_caud = 0.9843, data represent ±SEM, n P4_et1_ctx = 3, n P10_et1_ctx = 6, n P4_PVD_ctx = 7, n P10_PVD_ctx = 7, n P4_lat_ctx = 2, n P10_lat_ctx = 2, n P4_caud_ctx = 2, n P10_caud_ctx = 2, n P4_et1_SVZ = 4, n P10_et1_SVZ = 7, n P4_PVD_SVZ = 6, n P10_PVD_SVZ = 6, n P4_lat_SVZ = 3, n P10_lat_SVZ = 2, n P4_caud_SVZ = 4, and n P10_caud_SVZ = 4, 3 independent trials). (L) KI-67 positive cells in the cortex (uninjured = uninj, injured = inj, subventricular zone = SVZ, lateral ventricle = lv, cortex = ctx, corpus callosum = cc, sensorymotor cortex = smctx, PVD, lateral = lat, caudal = caud, tdTOMATO = TOM, and tamoxifen = TAM). See also Figure S1 and Table S1 .
To test this, AraC was infused for 10 days prior to stroke in the triple transgenic mice and the NS assay was performed 4 days later (AraC, 10 days+ and 4 daysÀ; Figure 1J (ii)). We observed the return of svzNSs as predicted, but no concomitant increase in the number of ctxNSs on day 4 ( Figure 1K ). Since the lack of ctxNS formation could be due to a delay in the migration of SVZ cells to the lesion site following AraC ablation and repopulation, we compared the number of ctxNSs at 7 days post stroke in AraC treated and untreated (stroke only) wild-type mice. Interestingly, we found no difference in the numbers of ctxNSs between these groups ( Figure S1J ). Notably, when we compared the number of ctxNSs at 4 and 7 days in AraC untreated stroke-injured mice, the number of ctxNSs at 7 days was significantly less than what was observed at 4 days (Figure 2A) . These findings suggest that repopulation of the SVZ occurs at the expense of migrating SVZ cells to the cortex. This may be the result of the cortical microenvironment being less attractive to migrating SVZ precursors at 7 days and/or the microenvironment prompting their differentiation at the site of injury.
SVZ Stem Cells Migrate to the Stroke Site and Give Rise to RAs Next, we examined the time course of migration of SVZ cells to the site of injury. We assayed for ctxNS formation following ET-1 stroke starting at 4 hr post stroke and continuing to 2 months post stroke. As seen in Figure 2A , we observed a gradual increase in the numbers of ctxNS from 1 to 4 days. After 4 days, there was a decrease in the numbers of ctxNSs until 10 days and by 2 months virtually no ctxNSs were detected (one sphere was formed from the cortex in one of eight animals; Figure 2A ). Consistent with the migration of SVZ cells to the site of injury, we observed YFP and tdTOMATO labeled cells ( Figure 2B ) at 2 and 4 days post stroke in the brain parenchyma of the stroke-injured mice. We characterized the SVZ derived parenchymal cells to determine the proliferation dynamics and phenotype of migratory YFP+ cells. EdU injections were given to NestinCreER T2 ;YFP fl mice for 2 or 4 days after stroke ( Figure 2C ), and the numbers and locations of YFP+/EdUÀ and YFP+EdU+ cells were assessed. YFP+ cells were seen in both the corpus callosum and the cortex with no difference in the relative percentage of YFP+EdU+ cells at 2 and 4 days post stroke (Figure 2D ). Further, we looked for doublecortin (DCX) expressing neuroblasts (YFP+/DCX+) en route to, and/or within, the injury site at 2 and 4 days post stroke and observed a small number of DCX+ cells in the corpus callosum ( Figure 2E ) at all times examined. However, no DCX+ cells were seen in the cortex at 2 days or 4 days post stroke even at a time of peak ctxNS formation ( Figure 2E ). YFP+ cells were never observed in the parenchyma of control (non-stroked) mice ( Figure 2F) . To determine if CSPG4+ cells contribute to cortical NS formation, we performed the NS assay in Cspg4-DsRed mice 4 days after stroke. We never observed DSRED+ ctxNSs (0/6 mice). These findings indicate that neither CSPG4+ cells nor migrating YFP+ DCX+ cells give rise to ctxNSs.
Irrespective of ctxNS formation, we consistently observed SVZ derived YFP+ cells in the cortex of stroke-injured NestinCreER T2 ;YFP fl mice from 2 days to 2 months post stroke ( Figures 2B and 3A) . We assessed whether the SVZ derived cells were contributing to injury-induced astrogliosis. The numbers of GFAP+ astrocytes among SVZ derived cells from the cortex of Nestin-CreER T2 ;YFP fl mice was assayed at 4, 7, and 10 days post stroke. Indeed, we observed a significant increase in the percentage of SVZ derived RAs (YFP+GFAP+) among total SVZ derived cells (YFP+) from 4 to 7 days and this increase was maintained at 10 days post stroke ( Figure 3B) . At 2 months, SVZ derived RAs were seen in the astroglial scar ( Figure 3A) . To further confirm our findings, we used the NestinCreER T2 ; tdTomato fl ;hGFAP-GFP mice. Quantification of SVZ derived cells in the cortex at 4, 7, and 10 days after stroke ( Figure S2A ) showed a decrease in the percentage of GFPÀ cells among total tdTOMATO+ cells ( Figure S2B) and an increase in the percentage of GFP+ cells among total tdTOMATO+ cells from 4 days to 7 days ( Figure 3B ). tdTOMATO+GFP+ cells were positive for S100b, further confirming astrocyte identity ( Figure S2C) . Given that tamoxifen fed control mice also had tdTOMATO signal in some of the vasculature in the brain (Figure S2D ), we may be underestimating the contribution of SVZ derived tdTOMATO+ data represent ±SEM, n 4d = 6 mice, n 7d = 7 mice, n 10d = 7 mice and one-way ANOVA with Tukey's post hoc, F(3,10) Tom+GFP+/Tom total = 5.5852 data represent ±SEM, n 4d = 3 mice, n 7d = 4 mice, and n 10d = 4 mice).
(C) Percentage of multipotent, bipotent, and astrocyte only ctxNSs (** = p < 0.01, *** = p < 0.001, and **** = p < 0.0001) (days, d) (z-test for independent proportions, z 4dvs7dmultipotent = 3.123 z 4dvs10dmultipotent = 3.9155, z 7dvs10dmultipotent = 0.8007, z 4dvs7dastrocyte_only = 3.5543 z 4dvs10dastrocyte_only = 3.9506, z 7dvs10dastrocyte_only = À0.3105, data represent n 4d = 14 NSs, n 7d = 12 NSs, and n 10d = 15 NSs) (tdTOMATO = TOM, subventricular zone = SVZ, lateral ventricle = lv, cortex = ctx, corpus callosum = cc, and tamoxifen = TAM). See also Figure S2 . cells to reactive astrogliosis. Together, these findings show that SVZ derived cells migrate to the injury site and differentiate into a population of RAs.
We took advantage of the NS assay to examine the differentiation potential of ctxNS to test the prediction that ctxNS would have a higher propensity to generate astrocyte only clones when isolated at later times post stroke. Indeed, we found that ctxNSs displayed reduced multipotency when isolated at 7 and 10 days post stroke (88% multipotent NSs at 4 days and 13.3% at 10 days post stroke; Figure 3C ). There was a concomitant increase in the number of ctxNSs producing astrocyte only colonies at later times post stroke (7% at 4 days and 80% at 10 days) ( Figure 3C ), Together, these findings support the hypothesis that SVZ derived cells migrate to the injury site post stroke and give rise to RAs.
SVZ Derived RAs Can Be Converted into Neurons
We next asked if the SVZ derived RAs could be converted to neurons. Cultures of RAs were established (S.G., unpublished data) from the stroke lesioned cortex of tamoxifen treated Nestin-CreER T2 ;YFP fl double transgenic mice ( Figure 4A ). Within the cultures, the GFAP+ and S100b+ astrocytes were invariably YFP+, revealing that their origin was from the SVZ and resident cortical (YFPÀ) astrocytes did not survive in our RA culture conditions ( Figure 4B) . Given that we observed small numbers of DCX+ SVZ derived cells en route to the lesion site post stroke, and the report by Seidenfaden et al. (2006) suggesting that neuroblasts can generate glial progeny in vivo, we sought to determine whether neuroblasts were a source of RAs in our cultures. We did this by magnetic activated cell sorting (MACS) PSA-NCAM positive cells (migratory neuroblasts) from the (legend continued on next page) injured cortex and establishing RA cultures from the column flow through (supernatant). RA cultures could not be established from the MACS sorted fraction. To validate the MACS sort, we performed ImageStream analysis on sorted and unsorted fractions from the injured cortex, the rostral migratory stream (RMS) (to control for PSA-NCAM+ neuroblasts), and the uninjured cortex. ImageStream analysis showed the presence of PSA-NCAM+ neuroblasts with intense punctate staining (bright detail intensity) on their surface in the sorted RMS fraction (Figures 4C and S3A ), but not in from the damaged cortex ( Figures  4C and S3B) or the uninjured contralateral cortex ( Figures 4C  and S3C ), consistent with no RA culture establishment from the sorted cortical fraction and the absence of dcx+ neuroblasts in the injured cortex at 4 days post injury in tissue sections. We confirmed that NS forming cells were not contaminating our RA cultures by plating cells derived from RA cultures in NS forming conditions ( Figure 4D) . No NSs were observed from 1-, 2-, 3-, and 4-day RA cultures ( Figure 4E ). To examine whether RAs could be converted to neurons, we established RA cultures from GFAP-CreER T2 ;YFP fl mice and forced expression of Ascl1, which alone or in combination with other factors has been successfully used to convert fibroblasts, hepatocytes, and astrocytes to neurons (Heinrich et al., 2010; Marro et al., 2011; Vierbuchen et al., 2010) . We used two different transfection systems: (1) PB-tet-O-Ascl1-T2A-Bfp, and (2) CAG-Ascl1-IRES-Dsred ( Figure 4F ). As predicted, we found that forced expression of Ascl1 resulted in conversion of RAs to TUJ1+ neurons (6/7 independent cultures showed successful conversion; Figure 4G) , with efficiencies ranging from 11%-100% ( Figure 4H ). We never observed TUJ1+ neurons in control (non-transfected) cultures (0/6 cultures). TUJ1+ cells co-expressed the mature neuronal marker MAP2 ( Figure S3D ), indicating that SVZ derived RAs can be converted to mature neurons by forced expression of a single transcription factor, Ascl1.
To test the possibility of converting SVZ derived RAs to neurons using only Ascl1 in vivo, we transduced GFAP+ RAs in tamoxifen fed and chased Nestin-CreER T2 ;YFP fl mice 7 days post stroke with either an AAV5-Gfap-Ascl1-T2A-mCherry or an AAV5-Gfap-mCherry control (Figures 4I and S3E) . This paradigm allowed us to assess conversion of GFAP+ RAs that were derived from the SVZ (YFP+). Interestingly, at 21 days post stroke, we observed rare YFP+mCHERRY+DCX+ cells (Figure 4J) and by 35 days YFP+mCHERRY+NEUN+ cells were seen within the cortex that persisted at 48 days post injury ( Figure 4K ). Conversion efficiencies using AAV5-Gfap-Ascl1-T2A-mCherry were 1.74 ± 1.27% at day 21 and 3.21 ± 1.1% at day 48 ( Figure 4L ). No NEUN+mCHERRY+ neurons were detected in AAV5-Gfap-mCherry transduced controls (0/4). Interesting, in vivo, Ascl1 conversion occurs in cells close to the lesion core where the host neurons have undergone cell death. These findings indicate that Ascl1 alone can be used to reprogram SVZ derived RAs, albeit at low efficiencies, in vivo.
DISCUSSION
Using a battery of genetic tools, we have shown that SVZ derived NSCs migrate to the damaged cortex after an injury, where a subpopulation will give rise to RAs. While previous studies (Buffo et al., 2008; Shimada et al., 2012) report de-differentiation of RAs to multipotent self-renewing cells, our work demonstrates the derivation of cortical NSs from SVZ derived precursors. Our triple transgenic paradigm allowed simultaneous tracking of SVZ precursors that express tdTOMATO activated by Nestin-CreER T2 prior to stroke and GFP driven by the GFAP promoter and astrocytes, which would only express GFP driven by GFAP. No GFP+ only NSs were seen, suggesting that RAs do not have the potential to form NSs after cortical injury. Rather, we show that NSCs leave their SVZ niche, migrate to the strokeinjured cortex, and retain their ability to form multipotent NSs when isolated in vitro. These findings were confirmed in the NestinCreER T2 ;YFP fl mice, where recombination frequencies in the cortex were similar to what was seen in the SVZ, supporting the hypothesis that ctxNSs originated from NSC migration from the SVZ to the damaged cortex. Further, ablation of dividing cells in the SVZ eliminated ctxNS formation.
It remains to be determined whether the different findings regarding the origin of NS forming cells are due to the different injury models employed. Stroke elicits a robust response in the SVZ (Arvidsson et al., 2002) and it is not clear if a similar response is seen after stab wound injury (Synowitz et al., 2006; Tzeng and Wu, 1999) . As such, the different cellular responses observed in response to injury may underlie the differences reported. Notably, cortical neurosphere formation has been reported from resident astrocytes after middle cerebral artery occlusion (MCAO) (Shimada et al., 2012; Sirko et al., 2013) , a more severe form of stroke that leads to significant cortical and subcortical lesions (Popp et al., 2009 ). Hence, the location of the injury (cortex versus striatum) may also play a role in determining the response of cells in the SVZ. Indeed, we know from previous studies that the striatum and cortex have distinct responses to injury (Fuentealba et al., 2015; Magnusson et al., 2014; Nato et al., 2015; Petit et al., 2001; Xu et al., 2001) . We purport that our findings complement the work of others (Buffo et al., 2008; Shimada et al., 2012; Sirko et al., 2013) and highlight that both the location and type of injury play a significant role in the cellular response of the brain to injury.
Further, comparing the results of our study with those reporting a different origin for ctxNSs following injury, one can consider the experimental techniques employed. For instance, previous studies that performed fate tracking of astrocytes utilized tamoxifen dependent recombination driven by Glast and Gfap promoters (Buffo et al., 2008; Shimada et al., 2012) , both of which are expressed by NSCs in the SVZ (Pastrana et al., 2009; Platel et al., 2009) . Given the considerable overlap between markers expressed by NSCs and RAs, such as nestin, GFAP, BLBP, and vimentin (Robel et al., 2011) , it is possible that Glast-and Gfap-mediated Cre recombination occurred in SVZ NSCs and, thus, SVZ derived cells could have contributed to the ctxNS formation observed following stab wound or MCAO injury. The methodologies used to prelabel SVZ cells and exclude their contribution to ctxNS formation following stab wound injury or MCAO relied on prelabeling SVZ cells with lentiviral vectors (Buffo et al., 2008) and DiI labeling (Shimada et al., 2012) . However, low frequency of lentiviral labeling and dilution of the DiI labeling could limit the conclusion that SVZ cells are not the source of ctxNSs following injury. Notably, our studies herein do not completely exclude the possibility that an ectopically labeled astrocyte gave rise to a ctxNS. Hence, the limitations of the paradigms employed must be considered when drawing conclusions regarding the origin of ctxNSs.
A number of studies have demonstrated that SVZ precursor cells also migrate to areas of injury in the adult brain (Arvidsson et al., 2002; Zhang et al., 2004) . We use a number of methodologies including lineage tracking, transgenic mice, and ablation paradigms that permit the selective loss of NS forming cells to show that migration post stroke is not limited to progenitor cells. We performed a rigorous analysis of the well-delineated properties of stem cells, multipotentiality, and self-renewal (Potten and Loeffler, 1990) , to demonstrate that SVZ derived NSCs migrate to the stroke lesion site. Further, immunohistochemistry and ImageStream analysis revealed that progenitor cells expressing DCX are not present in the stroke-injured cortex at the time when we see peak ctxNS formation. Together, these findings reveal that ctxNSs in the lesion site post stroke are derived from SVZ NSCs.
Perhaps our most interesting finding is that the NSCs that migrate to the stroke-injured cortex give rise to RAs. The SVZ derived RAs that contribute to the gliotic response at later times post injury add to the heterogeneity observed within the RA population and may play specific roles in neural repair. Indeed, a recent study points to specific roles of SVZ derived RAs in postnatal hypoxia/ischemia; SVZ derived RAs expressed higher levels of thrombospondin-4 and were responsible for proper scar formation and reduction of microvascular hemorrhaging (Benner et al., 2013) . Moreover, a recent article showed no evidence for human cortical neurogenesis after stroke using carbon dating techniques (Huttner et al., 2014) and may point to an alternate role of the SVZ in producing RAs after stroke.
A number of studies have shown that developmental signaling pathways involved in early astrogliogenesis (Bauer et al., 2007; Yang et al., 2013) are reactivated post injury (Bauer et al., 2007) . Further elucidation of the roles of signaling pathways such as the janus kinase/signal transducer and activator of transcription (JAK/STAT), and cytokines such as cardiotrophin-1 (CT-1), leukemia inhibitory factor (LIF), and ciliary neurotrophic factor (CNTF) (Yang et al., 2013) will lead to a clearer understanding of the subpopulations of RAs and their involvement in repair mechanisms after stroke. Further, epigenetic modifications that allow binding of transcriptional factors to astrocyte promoters and activate their expression may be the mechanism whereby cytokines exert their effect on astrocyte differentiation (Yang et al., 2013) .
The ''lack of success'' from transplantation paradigms and endogenous neurogenesis (Dibajnia and Morshead, 2013) could be the result of astrocyte differentiation favored over neuronal differentiation. Indeed, Shimada et al. (2012) showed a loss of neurogenic potential of transplanted cortical derived neurospheres following transplantation back into the uninjured brain; only astrocytes and oligodendrocytes were produced. Nonetheless, the existence of a multipotent cell in the cortex after stroke offers the possibility of manipulating these cells for brain repair. Along these lines, Ascl1 was reported to promote neurogenesis from NSCs (Kim et al., 2009 ) and astrocytes (Corti et al., 2012) and is a key regulator of fibroblast to neuron conversion in vitro (Chanda et al., 2014) . We used Ascl1 to target the progeny of SVZ derived cells and have shown that it is sufficient to convert these cells to neurons, both in vitro and in vivo. Hence, SVZ derived RAs may provide a target for neural repair. The low conversion efficiency of these cells in vivo may reflect regional/age differences in the brain, as has been suggested by recent studies targeting endogenous glia for cellular conversion (Guo et al., 2014; Heinrich et al., 2010 Heinrich et al., , 2011 Heinrich et al., , 2014 Niu et al., 2013; Pollak et al., 2013; Su et al., 2014) . Given the cellular heterogeneity that has been reported, it is likely that cells in different regions may respond differently to transcription factors and other stimuli. Cells that migrate to the cortex, for example, may be intrinsically different or undergo different specification than those that migrate to the striatum, such that transcription factors used successfully in one brain region may not directly translate to another. Indeed, Ascl1 is endogenously upregulated in resident astrocytes in the striatum after stroke (Magnusson et al., 2014) and has been used successfully in combination with other transcription-factors in the striatum (Torper et al., 2013) . Ascl1 alone is sufficient to convert Muller glia into neurogenic progenitors in the retina (Pollak et al., 2013) . More importantly, it remains to be seen if manipulating these cells will be beneficial or detrimental to tissue regeneration in vivo. A clearer understanding of subpopulations of RAs and their involvement in repair mechanisms may help us to identify the best cell type for therapeutic cell conversion.
EXPERIMENTAL PROCEDURES
Mice C57BL/6J and hGFAP-GFP mice (Zhuo et al., 1997) were used to assess ctxNS formation. GFAP-TK mice (Bush et al., 1998) were used for selective ablation of GFAP+ NS forming cells. For analysis of the origin of stem cells in the cortex, Nestin-CreER T2 mice (Imayoshi et al., 2006) were crossed with tdTomato fl mice (Madisen et al., 2010) and Nestin-CreER T2 mice (Lagace et al., 2007) were crossed with YFP fl mice (Srinivas et al., 2001) , resulting in Nes-CreER T2 ;tdTomato fl and Nestin-CreER T2 ;YFP fl mice. Nestin-CreER T2 ; tdTomato fl mice were crossed to hGFAP-GFP mice, resulting in Nestin-CreER T2 ;tdTomato fl ;hGFAP-GFP mice. In addition, Cspg4-DsRed mice (Zhu et al., 2008) were used. For RA conversion experiments, GFAP-CrER T2 mice (Casper et al., 2007) were crossed to YFP fl transgenic mice, resulting in GFAP-CreER T2 ;YFP fl transgenic mice.
Experiments were conducted according to protocols approved by the Toronto Centre for Phenogenomics and the Department of Comparative Medicine of the University of Toronto.
ET-1 Stroke 1 ml of 400 pmolar ET-1 (Calbiochem) was injected stereotaxically into the cortex at 0.6 anterior-posterior (AP), 2.25 medial-lateral (ML), À1 dorsal-ventral (DV) (sensory-motor cortex coordinates); À1.7 AP, +4 ML, À3 DV (lateral coordinates); or À2.3 AP, +2 ML, À0.5 DV (caudal coordinates), relative to bregma.
PVD Stroke PVD strokes were induced by removing the skull and dura in the region bound by 0.5 to +2.5 AP and +0.5 to 3 ML, relative to bregma. A saline-soaked cotton swab was used to remove pial vessels.
Tamoxifen Induction
Animals were fed tamoxifen food (0.5% TAM and 5% sucrose; Harlan) for 2 weeks followed by a chase period of 2-3 weeks.
Adeno Associated Viral Injections 1 ml of AAV5-Gfap-Ascl1-T2A-mCherry or AAV5-Gfap-mCherry particles (Vec-torBioLabs) were injected into the cortex of NestinCreER T2 ;YFP fl mice 7 days post stroke.
NS Culture
NSs were cultured as previously described (Coles-Takabe et al., 2008; Tropepe et al., 1997) . Cells were plated at clonal density (5 cells/mL).
RA Culture and Conversion
The cortex was dissected from GFAP-CreER T2 ;YFP fl mice. Cells were plated in astrocyte media with 1 mM 4-OH-TAM. After 7 days, cells were transfected with PBase, PB-CAG-rtTA (Woltjen et al., 2009) , and PBÀtetO-Ascl1-T2A-Bfp or CAG-Ascl1-IRES-Dsred using HD Fugene (Roche). The media was changed to N2B27. For PBÀtetO-Ascl1-T2A-Bfp expression, 1,500 ng/mL dox was added.
MACS and ImageStream Analysis
Cells were stained with anti-PSA-NCAM-PE (Miltenyi Biotech) and MACS sorted. For ImageStream analysis, cells were stained with a fixable cell viability dye (FVD eFluor 780; eBioscience), anti-PSA-NCAM-PE (Miltenyi Biotech), or a mouse IgM-PE control (Miltenyi Biotech), MACS sorted and stained with Hoescht (BD Biosciences). Cells were analyzed with an Amnis Image-StreamTM Mark II imaging flow cytometer (Amnis) and compensated image files were analyzed using IDEAS analysis software (Amnis).
Statistical Analysis
All experiments were conducted blind, using a numbering system. F tests were used to compare variance between groups. Unpaired two-tailed t tests or unpaired two-tailed t tests with Welch's correction (for unequal variance) were used for comparisons between two groups. A one-factor ANOVA was used followed by post hoc analysis (Tukey's or Dunnet's test) for comparisons between three or more groups. Comparison of percentages between groups was done using two sample z-tests for individual proportions. Differences were considered significant at p < 0.05. Values are presented as mean ± SEM.
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